Cap-dependent endonuclease inhibitors (CENis) - NHRC

Estimated Value: $500,000
Closing Soon 3 days left VAHealthcarerfp
May 15, 2026
May 25, 2026 9:00 PM
Healthcare
rfp
541715
AI Summary
This bid is for the preclinical development of Cap-dependent endonuclease inhibitors (CENis) as broad-spectrum antiviral therapeutics, including activities required to select lead candidates.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Preclinical development services for Cap-dependent endonuclease inhibitors (CENis) 1 lot $500,000.00 $500,000.00 Professional Services
Lead CENi candidate selection services 1 lot Professional Services
Estimated Bid Value$500,000.00

Want the full details?

Sign up free to see the agency name, 3 documents, contact info, and the original bid posting link.

📎 Solicitation_-_N0018926QB059.pdf View
📎 Combined_Synopsis.pdf View
📎 PWS_CENi_RFQ.pdf View
Sign Up Free →

Related Bids

Browse More Bids

Bids in VirginiaHealthcare BidsRFP BidsClosing Soon All Bids